Venus Remedies receives Gabon Authority approval for Panchkula and Baddi units, expanding global reach with GMP-compliant manufacturing excellence.

Saransh Chaudhary highlights how India’s Union Budget 2026–27 marks a decisive shift toward science-driven pharma growth and stronger healthcare foundations.

Securing 75% of the eligible FY 2024–25 PLI incentive, Venus Remedies reaffirms its manufacturing excellence, consistent performance, and commitment to strengthening India’s pharmaceutical ecosystem.

Mr. Saransh Chaudhary, President – Global Critical Care, Venus Remedies, and CEO, Venus Medicine Research Centre, shared his views on the recent labelling reforms announced by the Central Drugs Standard Control Organization (CDSCO) in Pharmabiz. He highlighted why these reforms are a timely and important step for India’s pharmaceutical

We are proud to share that Venus Remedies received new marketing authorizations, including a significant regulatory accomplishment in Indonesia for its antibiotic combination, Ceftazidime + Avibactam.This marks Venus Remedies’ entry in the anti-infective segment in Indonesia, and the product will become the first generic version of Ceftazidime + Avibactam launched. It

The new year started with a grand Officers & Management Meet at Venus Remedies. Our esteemed leadership and the HODs came together to reflect on the achievements of 2025, set goals for 2026, and celebrate the winners of the KBC 2025 championship.The event was made extra special by

The New Year at Venus Remedies was welcomed with a sense of optimism, reflection, and shared purpose. As teams across the organisation came together to mark the first day of the year, the focus remained on setting the right tone for the months ahead. The occasion was not just about

2025 was a year of steady progress at Venus Remedies—shaped by collaboration, responsibility, and a continued focus on quality across teams and locations. From global platforms to internal initiatives and community programs, the year reflected how progress is built through people working together with purpose.Recognition That Motivated UsRecognition

Progress is rarely instant. It grows through steady effort, learning on the job, and the discipline to improve every day. At Venus Remedies, we believe that continuous upskilling is essential to staying relevant and capable in a fast-evolving industry.Learning here is not treated as a one-time achievement. It is

Every year, the world comes together from 18–24 November to observe World Antimicrobial Awareness Week—a global movement dedicated to understanding antimicrobial resistance (AMR) and encouraging the responsible use of antibiotics. At Venus Remedies Ltd., this week is more than an observance. It is a reminder of

We are delighted to share an important milestone for all of us at Venus Remedies. An article written by Saransh Chaudhary, President – Global Critical Care & CEO – Venus Medicine Research Centre, has been featured in the Hindustan Times, one of India’s most trusted news platforms. This

November 2025 has been a special month for us at Venus Remedies. We are proud to share that we have received several new Marketing Authorizations across important global markets. Each approval brings us one step closer to our goal of making advanced oncology and critical care medicines accessible to more

Quality Week 2025 at Venus Remedies was celebrated on a meaningful and uplifting note across our Baddi and Panchkula units. The entire week brought teams together through learning sessions, open interactions, and hands-on activities that highlighted the importance of quality in everything we do. By the time we reached the

Guided by a strong sense of purpose, Venus Remedies continued to push the boundaries of global healthcare accessibility and innovation at CPHI 2025.At CPhI 2025, we strengthened our commitment to improving access to quality healthcare worldwide. Together, we showcased how our science, people, and partnerships continue to drive meaningful

Venus Remedies has become a leader in oncology, critical care, and antimicrobial resistance solutions. Guided by research-focused manufacturing and a customer-first approach, the company serves customers in over 100 countries and continues to set high standards for quality, compliance, and access to medicines.Keeping up with its excellence, Venus Remedies

Venus Remedies continues to strengthen its footprint across the world with a new series of Marketing Authorizations (MAs) granted in key international markets. This achievement marks another important step in the company’s long-standing commitment to expanding access to high-quality oncology, antibiotic, and critical care therapies. As healthcare

At Venus Remedies, we believe every achievement—big or small—deserves to be celebrated. Our culture is built on acknowledging the dedication of our people while also creating opportunities to unwind, connect, and enjoy moments together. Recognition is not just about awards; it is about valuing the spirit of ownership,

At Venus Remedies, we firmly believe that healthcare goes beyond developing life-saving medicines—it is also about ensuring that every medicine is safe, reliable, and trusted by those who use it. In line with this commitment, we actively participated in National Pharmacovigilance Week 2025, observed under the theme “Your

At Venus Remedies, our mission has always been simple but powerful: to make life-saving medicines accessible to patients wherever they are needed. In every corner of the world, people depend on safe, effective, and affordable treatments, and it is our responsibility to ensure they have access to them. Each approval

Medicines save lives, but the way we create and deliver them is always changing. At Venus Remedies, we put digital transformation at the heart of this change, helping us improve every part of healthcare. From how we do research to how medicines reach patients, technology lets us work faster, make

At Venus Remedies, every milestone reflects our commitment to progress, care, and responsibility. The Venus Army has always stood as more than just a team—it is an effort that blends innovation with compassion, serving patients, communities, and colleagues alike.This year marks a defining moment in its journey as

At Venus Remedies, we believe every new approval is more than just a milestone—it is a step closer to saving lives. Recently, we achieved several important global approvals that bring us closer to patients in need across the world.These approvals show our growing presence in international markets and

Metallo-β-lactamases (MBLs) are among the most dangerous enzymes produced by drug-resistant bacteria. They render last-line antibiotics like carbapenems ineffective—posing a serious threat to critical care treatment in India and across the globe. With the rising rates of antimicrobial resistance (AMR), particularly in Gram-negative infections, the development

Venus Remedies is honored to receive the marketing authorization for Bendamustine in Saudi Arabia, one of the strictly regulated global pharmaceutical markets. This approval is another notable addition to its extensive list of achievements and a significant step toward enhancing access to vital cancer treatments in the GCC and MENA